Zdrowie i gospodarka · 14/12/2018
FDA Withdraws Proposed Rule on Labeling Changes for Approved Drugs and Biological Products
The US Food and Drug Administration (FDA) has withdrawn a proposed rule from 2013, which aimed to update labeling for approved drugs and biological products, following concerns from commenters and resource considerations.
Source: Federal Register — Food and Drug AdministrationOpen original release →